MedPath

OPTIMARK

OPTIMARK

Discontinued
DIN Number

02242986

Drug Class

Human

Market Date

Aug 20, 2001

Company
HC

liebel-flarsheim canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242986
AIG Number0142281001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA06 GADOVERSETAMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

GADOVERSETAMIDEActive
Strength: 330.9 MG / ML
Monograph: GADOVERSETAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.